Clinical features and natural history of progressive supranuclear palsy - A clinical cohort study

被引:168
|
作者
Nath, U
Ben-Shlomo, Y
Thomson, RG
Lees, AJ
Burn, DJ
机构
[1] Univ Newcastle Upon Tyne, Sch Hlth Sci, Dept Neurol, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England
[2] Univ Newcastle Upon Tyne, Sch Hlth Sci, Dept Epidemiol & Publ Hlth, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England
[3] Univ Bristol, Dept Social Med, Bristol BS8 1TH, Avon, England
[4] Reta Lila Weston Inst Neurol Sci & Sara Koe PSP R, Inst Neurol, London, England
关键词
D O I
10.1212/01.WNL.0000052991.70149.68
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Objective: To describe clinical features and identify prognostic predictors in progressive supranuclear palsy (PSP) Methods: Record-based diagnosis according to National Institute of Neurological Disorders and Stroke-Society for Progressive Supranuclear Palsy criteria was performed in 187 cases of PSP. Clinical information was abstracted from patient records. Sixty-two patients (33%) were examined by the investigators. Forty-nine of 62 patients (79%) underwent standardized clinical assessment. Predictors of survival were examined after a mean of 6.4 years. Results: The most common symptoms at disease onset related to mobility (69%). Of patients undergoing standardized clinical assessment, diplopia occurred in 61%, photophobia in 43%, and eyelid apraxia in 43%. Seventy-five cases (40%) died during follow-up. Older age at onset and classification as probable PSP were associated with poorer survival. Onset of falls (hazard ratio 3.28, 95% CI 1.17 to 9.13), speech problems (hazard ratio 4.74, 95% CI 1.10 to 20.4), or diplopia (hazard ratio 4.23, 95% CI 1.23 to 14.6) within 1 year and swallowing problems within 2 years (hazard ratio 3.91, 95% CI 1.39 to 11.0) were associated with a worse prognosis. Conclusions: Mobility problems are the commonest early feature in PSP and visual symptoms are often functionally disabling. Early falls, speech and swallowing problems, diplopia, and early insertion of a percutaneous gastrostomy predict reduced survival.
引用
收藏
页码:910 / 916
页数:7
相关论文
共 50 条
  • [21] Clinical diagnosis of progressive supranuclear palsy
    Litvan, I
    [J]. MOVEMENT DISORDERS, 2004, 19 (03) : 357 - 357
  • [22] Natural history of patients with progressive supranuclear palsy
    Nunomura, J. I.
    Matsunaga, M.
    Ono, H.
    [J]. MOVEMENT DISORDERS, 2013, 28 : S299 - S299
  • [23] Clinical features and natural course of corticobasal degeneration and progressive supranuclear palsy presenting as corticobasal syndrome
    Aiba, I.
    Yoshida, M.
    Shimohata, T.
    Hayashi, Y.
    Sano, T.
    Saito, Y.
    Murayama, S.
    Hasegawa, K.
    Iwasaki, Y.
    Sakai, M.
    Wakabayashi, K.
    Komori, T.
    Nakashima, K.
    [J]. MOVEMENT DISORDERS, 2020, 35 : S501 - S501
  • [24] Clinical heterogeneity of progressive supranuclear palsy
    Khatiashvili, I.
    Yakhno, N. N.
    [J]. EUROPEAN JOURNAL OF NEUROLOGY, 2004, 11 : 110 - 111
  • [25] Impact of Aspiration Pneumonia on the Clinical Course of Progressive Supranuclear Palsy: A Retrospective Cohort Study
    Tomita, Satoshi
    Oeda, Tomoko
    Umemura, Atsushi
    Kohsaka, Masayuki
    Park, Kwiyoung
    Yamamoto, Kenji
    Sugiyama, Hiroshi
    Mori, Chiaki
    Inoue, Kimiko
    Fujimura, Harutoshi
    Sawada, Hideyuki
    [J]. PLOS ONE, 2015, 10 (08):
  • [26] Natural history of progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome) and clinical predictors of survival: A clinicopathological study
    Litvan, I
    Mangone, CA
    McKee, A
    Verny, M
    Parsa, A
    Jellinger, K
    DOlhaberriague, L
    Chaudhuri, KR
    Pearce, RKB
    [J]. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 1996, 60 (06): : 615 - 620
  • [27] PREVALENCE AND NATURAL-HISTORY OF PROGRESSIVE SUPRANUCLEAR PALSY
    GOLBE, LI
    DAVIS, PH
    SCHOENBERG, BS
    DUVOISIN, RC
    [J]. NEUROLOGY, 1988, 38 (07) : 1031 - 1034
  • [28] Clinical outcomes of two main variants of progressive supranuclear palsy and multiple system atrophy: a prospective natural history study
    Milica Jecmenica-Lukic
    Igor N. Petrovic
    Tatjana Pekmezovic
    Vladimir S. Kostic
    [J]. Journal of Neurology, 2014, 261 : 1575 - 1583
  • [29] TREATMENT OF PROGRESSIVE SUPRANUCLEAR PALSY WITH METHYSERGIDE - A CLINICAL-STUDY
    DITRAPANI, G
    STAMPATORE, P
    LACARA, A
    AZZONI, A
    VACCARIO, ML
    [J]. ITALIAN JOURNAL OF NEUROLOGICAL SCIENCES, 1991, 12 (02): : 157 - 161
  • [30] Clinical outcomes of two main variants of progressive supranuclear palsy and multiple system atrophy: A prospective natural history study
    Lukic, M. Jecmenica
    Petrovic, I.
    Tomic, A.
    Svetel, M.
    Pekmezovic, T.
    Kostic, V. S.
    [J]. MOVEMENT DISORDERS, 2014, 29 : S110 - S111